Listening Session: Advocates for Biomedical and Translational Research and General Medicine

The National Institutes of Health and the White House Office of Science and Technology Policy are organizing a series of listening sessions to get feedback from patient advocacy groups, industry, scientific professional organizations, and other stakeholders. These listening sessions will vary in format from broad, public discussions to smaller, invitation-only meetings to discuss more sensitive information. These sessions will help lay the foundation for the Advanced Research Projects Agency for Health (ARPA-H). 

Listening session 7: Advocates for Biomedical and Translational Research and General Medicine will convene stakeholders in the areas of biomedical research, translational research and general medicine.